» Articles » PMID: 37393897

Virtual Learning and Youth-Onset Type 2 Diabetes During the COVID-19 Pandemic

Overview
Publisher Karger
Date 2023 Jul 2
PMID 37393897
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cases and severity of presentation of youth-onset type 2 diabetes (Y-T2D) increased during the COVID-19 pandemic, yet the potential drivers of this rise remain unknown. During this time public health mandates paused in-person education and limited social interactions, resulting in radical lifestyle changes. We hypothesized that the incidence and severity of presentation of Y-T2D increased during virtual learning amidst the COVID-19 pandemic.

Materials And Methods: We conducted a single-center retrospective chart review to identify all newly diagnosed cases of Y-T2D (n = 387) at a pediatric tertiary care center in Washington, DC during three predetermined learning periods as defined by learning modality in Washington, DC Public Schools: pre-pandemic in-person learning (March 11, 2018-March 13, 2020), pandemic virtual learning (March 14, 2020-August 29, 2021), and pandemic in-person learning (August 30, 2021-March 10, 2022) periods.

Results: Incident cases were stable during pre-pandemic in-person learning (3.9 cases/month, 95% CI: 2.8-5.4 cases/month), increased to a peak during virtual learning (18.7 cases/month, 95% CI: 15.9-22.1 cases/month), and declined with return to in-person learning (4.3 cases/month, 95% CI: 2.8-6.8 cases/month). Y-T2D incidence was 16.9 (95% CI: 9.8-29.1, p < 0.001) and 5.1-fold higher (95% CI: 2.9-9.1, p < 0.001) among non-Hispanic Black and Latinx youth, respectively, throughout the study period. Overall COVID-19 infection rates at diagnosis were low (2.5%) and were not associated with diabetes incidence (p = 0.26).

Conclusions: This study provides timely insights into an important and modifiable correlate of Y-T2D incidence, its disproportionate impact on underserved communities, and the need to consider the effects on long-term health outcomes and preexisting healthcare inequities when designing public policy.

References
1.
Chao L, Vidmar A, Georgia S . Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic. Diabetes Care. 2021; 44(6):1451-1453. PMC: 8247527. DOI: 10.2337/dc20-2733. View

2.
Dandona P, Aljada A, Bandyopadhyay A . Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2003; 25(1):4-7. DOI: 10.1016/j.it.2003.10.013. View

3.
Roca-Ho H, Riera M, Palau V, Pascual J, Soler M . Characterization of ACE and ACE2 Expression within Different Organs of the NOD Mouse. Int J Mol Sci. 2017; 18(3). PMC: 5372579. DOI: 10.3390/ijms18030563. View

4.
Bruehl H, Rueger M, Dziobek I, Sweat V, Tirsi A, Javier E . Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes. J Clin Endocrinol Metab. 2007; 92(7):2439-45. DOI: 10.1210/jc.2006-2540. View

5.
Parolin Z, Lee E . Large socio-economic, geographic and demographic disparities exist in exposure to school closures. Nat Hum Behav. 2021; 5(4):522-528. PMC: 8060162. DOI: 10.1038/s41562-021-01087-8. View